Wells Fargo Reiterates Overweight on Boston Scientific, Maintains $62 Price Target
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Larry Biegelsen has reiterated an Overweight rating on Boston Scientific (NYSE:BSX) and maintained a price target of $62.

December 29, 2023 | 11:51 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wells Fargo analyst reaffirms Overweight rating on Boston Scientific with a $62 price target, indicating a positive outlook on the stock.
The reiteration of an Overweight rating by a major financial institution like Wells Fargo typically instills confidence in investors and can lead to a positive short term impact on the stock price. The maintenance of a $62 price target suggests that the analyst sees potential for the stock to rise to that level, which is a bullish signal.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100